13F-HR filed by Seven Fleet Capital Management LP
Seven Fleet Capital Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:11:48 UTC, with 85 holding rows worth $511,733,165.
- Accession
- 0001013594-26-001198
- Filer
- CIK 2092021
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 101 entries on the cover page, a total value of $511,733,165 stated on the cover page (in dollars after the unit check, H1), rows summing to $511,733,165 with VALUE read as dollars as filed, 13F file number 028-26709. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerDV Trading LLC028-26555
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,886,236 | $133,715,270 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,232,864 | $55,709,957 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 264,588 | $54,309,333 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 700,084 | $22,206,664 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 6,862,744 | $19,970,585 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 596,275 | $18,043,282 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 451,173 | $13,661,518 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 261,957 | $12,008,109 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 772,660 | $11,844,878 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 444,937 | $11,101,178 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 290,280 | $10,615,540 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 99,274 | $9,830,111 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 417,441 | $9,805,689 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 80,000 | $9,698,400 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 45,659 | $6,432,897 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 288,439 | $6,137,982 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 4,421,739 | $6,083,133 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 572,267 | $5,207,630 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 24,066 | $4,437,530 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 429,113 | $4,239,636 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,504,231 | $4,166,720 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 108,647 | $4,135,105 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 46,432 | $4,088,338 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 350,000 | $3,825,500 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 48,530 | $3,814,943 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 687,240 | $3,660,927 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 750,000 | $3,652,500 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 53,748 | $3,542,531 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,001,373 | $3,354,600 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 185,733 | $3,352,481 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 118,395 | $3,118,524 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 10,489 | $3,054,711 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,085,398 | $2,952,283 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,915,871 | $2,944,802 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 752,772 | $2,386,287 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 9,440 | $2,150,715 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 116,185 | $1,858,960 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 99,894 | $1,609,292 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,940 | $1,593,157 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 414,341 | $1,528,918 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 37,900 | $1,487,954 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 254,309 | $1,352,924 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 40,868 | $1,324,532 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 76,648 | $1,296,118 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 22,066 | $1,255,555 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 100,000 | $1,251,000 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 86,654 | $1,162,897 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 81,221 | $1,084,300 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 11,611 | $1,033,727 | dollars as filed | |
| INMED PHARMACEUTICALS INC | 457637700 | COM NEW | 1,069,519 | $1,000,000 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 84,590 | $974,477 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 40,000 | $900,800 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 296,087 | $814,239 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 358,460 | $736,635 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 240,963 | $656,624 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 19,326 | $618,819 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 158,253 | $564,963 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 18,558 | $540,038 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 371,411 | $534,832 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 34,976 | $512,748 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 140,000 | $466,200 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 14,710 | $419,088 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 14,700 | $408,954 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 6,810 | $399,202 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 15,844 | $387,386 | dollars as filed | |
| QUINCE THERAPEUTICS INC COM | 22053A305 | Stock | 11,989 | $371,779 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 272,204 | $367,475 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 39,500 | $346,810 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 6,395 | $318,599 | dollars as filed | |
| GERON CORP | 374163103 | COM | 258,900 | $318,447 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 23,077 | $316,847 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 7,950 | $305,439 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 10,204 | $303,467 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 12,000 | $279,480 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 4,100 | $268,386 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 48,745 | $255,911 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 51,700 | $242,732 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 44,200 | $232,492 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 193,034 | $200,755 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 137,100 | $167,262 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 16,000 | $134,080 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 10,600 | $115,010 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 34,161 | $75,154 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 10,000 | $48,400 | dollars as filed | |
| PROCESSA PHARMACEUTICALS INC | 74275C403 | COM SHS | 18,300 | $30,012 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-26-001198 | this filing | 2026-11-16 |